These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21317584)
1. Probiotics: the potential for a live microbicide to prevent HIV. Hemmerling A; Cohen CR J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e98-101. PubMed ID: 21317584 [No Abstract] [Full Text] [Related]
2. Report from the 16th Conference on Retroviruses and Opportunistic Infections. First (sort of) positive anti-HIV microbicide trial. del Rio C J Watch AIDS Clin Care; 2009 Apr; 21(4):34. PubMed ID: 19544618 [No Abstract] [Full Text] [Related]
3. 'We need a microbicide now!'. Smart T IAPAC Mon; 2006 Apr; 12(4):114. PubMed ID: 17233098 [No Abstract] [Full Text] [Related]
8. Microbicide research already benefiting thousands--experts. Bateman C S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283 [No Abstract] [Full Text] [Related]
9. Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide. Bélec L; Jenabian MA; Charpentier C; Saïdi H Future Microbiol; 2011 Jul; 6(7):731-7. PubMed ID: 21797688 [TBL] [Abstract][Full Text] [Related]
10. A successful history: probiotics and their potential as antimicrobials. Santacroce L; Charitos IA; Bottalico L Expert Rev Anti Infect Ther; 2019 Aug; 17(8):635-645. PubMed ID: 31318576 [No Abstract] [Full Text] [Related]
11. South Africa's experience of the closure of the cellulose sulphate microbicide trial. Ramjee G; Govinden R; Morar NS; Mbewu A PLoS Med; 2007 Jul; 4(7):e235. PubMed ID: 17685664 [TBL] [Abstract][Full Text] [Related]
12. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction. Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845 [TBL] [Abstract][Full Text] [Related]
13. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Microbicide research-streamlining the process. Cates W AIDS; 2001 Feb; 15 Suppl 1():S64-5. PubMed ID: 11403010 [No Abstract] [Full Text] [Related]
14. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Mauck CK; Schwartz JL Sex Transm Dis; 2012 Sep; 39(9):713-5. PubMed ID: 22902668 [No Abstract] [Full Text] [Related]
15. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. McGowan I; Taylor DJ Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687 [TBL] [Abstract][Full Text] [Related]
16. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission. Sepúlveda-Crespo D; Sánchez-Rodríguez J; Serramía MJ; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ Nanomedicine (Lond); 2015; 10(6):899-914. PubMed ID: 25867856 [TBL] [Abstract][Full Text] [Related]